EyePoint Inc. (NASDAQ: EYPT) announced that an independent Data Safety Monitoring Committee recommended continuing both Phase 3 trials of its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE